|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Top Lists |
Insider Trading Graph View |
Insider Watch |
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise" - Peter Lynch ==>> What is insider trading>> |

| Transaction & Date | Reported Date |
Exercisable Expiration |
Company | Symbol | Insider Relationship | Shares Traded | Conversion Price |
Shares Ownership |
Filing |
| 2008-06-10 Option Award |
2008-06-12 6:30 pm | N/A 2018-06-10 |
SCICLONE PHARMACEUTICALS INC | SCLN | Hawkins Richard J (Director) | 30,000 | $1.75 | 30,000 (Direct) | View |
| 2007-12-19 Option Award |
2008-02-11 5:07 pm | 2008-01-19 2017-12-19 |
CYTORI THERAPEUTICS, INC. | CYTX | Hawkins Richard J (Director) | 50,000 | $5.13 | 50,000 (Direct) |
View |
| 2007-12-19 Option Award |
2007-12-21 5:34 pm |
2008-01-19 2017-12-19 | CYTORI THERAPEUTICS, INC. | CYTX | Hawkins Richard J (Director) | 50,000 | $5.13 | 50,000 (Direct) |
View |
| 2007-06-13 Option Award |
2007-06-15 7:49 pm | N/A 2017-06-13 |
SCICLONE PHARMACEUTICALS INC | SCLN | Hawkins Richard J (Director) | 30,000 | $2.61 | 30,000 (Direct) |
View |
| 2006-06-13 Option Award | 2006-06-15 7:10 pm |
N/A 2016-06-13 | SCICLONE PHARMACEUTICALS INC | SCLN | Hawkins Richard J (Director) | 30,000 | $2.46 | 30,000 (Direct) | View |
| 2005-06-07 Option Award | 2005-06-09 4:44 pm | N/A 2015-06-07 | SCICLONE PHARMACEUTICALS INC | SCLN | Hawkins Richard J (Director) | 15,000 | $3.27 | 15,000 (Direct) |
View |
| 2004-10-29 Option Award |
2004-11-02 7:48 pm | N/A 2014-10-29 |
SCICLONE PHARMACEUTICALS INC | SCLN | Hawkins Richard J (Director) | 50,000 | $4.55 | 50,000 (Direct) | View |
|
© 2005-2008 SecForm4.Com All rights reserved. Archives: 2008 2007 2006 2005 2004 2003 Thu, 04 Dec 2008 01:17:47 -0600 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC. SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |